Minute Insights
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Minute Insight: Dutch Grant Funds Antibiotic Resistance Test
SoundCell BV and Applied Nanolayers are using genetically engineered E.Coli contained in a graphene chip to test for antibiotic resistance.
Minute Insight: Theranica’s Wearable Earns Expanded FDA Clearance For Preventing Migraines
Theranica’s expanded US FDA clearance allows the company to market its prescription-based wearable as both an acute and preventive treatment for migraine headaches.
Minute Insight: Vytalize Raises $100M To Advance Value-Based Care For Seniors
After raising $50m in a series B funding round last April, value-based care platform Vytalize has raised another $100m to build out its clinical support platform for primary care doctors.
Minute Insight: Medtronic Relaunches Harmony Pulmonary Valve Replacement
The company pulled Harmony from the market about a year ago following six reports of the capsule at the end of its delivery catheter breaking.
Minute Insight: Medtronic’s Extravascular ICD Earns European Approval
The Aurora extravascular implantable cardioverter defibrillator and the Epsila extravascular lead earned a CE mark supported by results from a global pivotal study.
Minute Insight: Insulet Acquires Insulin Pump Patents From Bigfoot, AGC
Insulet will acquire insulin pump patents from Bigfoot Biomedical for $25m, which Bigfoot will use to expand its Unity diabetes management system. Insulet also announced the acquisition of automated insulin delivery assets held by Automated Glucose Control.
Minute Insight: J&J Monarch Robot Removes Kidney Stone With Mini-PCNL Procedure
The company is sponsoring the first clinical study of robotically assisted electromagnetic-guided percutaneous access and mini-percutaneous nephrolithotomy – kidney stone removal – with the Monarch robotic-assisted platform for urology.
Minute Insight: Abbott Wins Expanded FDA Approval For Proclaim XR Spinal Cord Stimulator For Diabetic Peripheral Neuropathy
Abbott said a major competitive benefit of the Proclaim XR SCS system is the battery life of up to 10 years at low settings.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Article
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.